Robert Greentree, CEO of Southlake Orthopaedics Sports Medicine & Spine Center, was honored at the Birmingham Business Journal's 2020 CEO Awards, the news outlet reported Jan. 8.
Author: Alan Condon
Full-year 2020 revenue for SeaSpine declined 3 percent year over year to between $154.1 million and $154.5 million, according to a preliminary unaudited report released Jan. 11.
Columbus, Ohio-based OrthoNeuro has strengthened its executive team with two promotions.
The University of New Mexico Health Sciences' Center of Excellence for Orthopedic Surgery and Rehabilitation in Rio Rancho, N.M., will be complete by the beginning of 2022, local news affiliate KRQE reports.
Norwood, Ohio-based Mayfield Brain & Spine CEO Mike Farrington will leave the practice Jan. 22 for an undisclosed healthcare-related job in New Jersey.
Advertisement
From two big-money acquisitions in the orthopedic space to a new CEO entering the fray, here is the latest device company news:
Full-year 2020 revenue for SI-Bone, a sacropelvic device company, increased 9 percent to between $73.1 million and $73.4 million year over year, according to a preliminary unaudited report on Jan. 7.
Hospital systems in metro Detroit are preparing to administer COVID-19 vaccines to patients aged 65 and older, with Southfield, Mich.-based Beaumont Health reaching out to more than 200,000 patients in its database, the Detroit Free Press reports.
From research into how poor bone quality could lead to complications after spinal fusion to positive results of a single-position spine surgery clinical trial, here are five recent studies catching the eyes of spine surgeons:
Neurosurgeons at Naval Medical Center San Diego completed the facility's first spine surgery with a 3D surgical microscope, according to Dvids.